Back to Search
Start Over
New therapies for relapsed or refractory aggressive B‐cell lymphoma increase survival: Analysis from the RELINF registry of the GELTAMO group.
- Source :
- HemaSphere; Apr2024, Vol. 8 Issue 4, p1-5, 5p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 25729241
- Volume :
- 8
- Issue :
- 4
- Database :
- Complementary Index
- Journal :
- HemaSphere
- Publication Type :
- Academic Journal
- Accession number :
- 178066838
- Full Text :
- https://doi.org/10.1002/hem3.70